D-0319-2024 Class II Terminated
FDA drug recall D-0319-2024 was initiated by Amneal Pharmaceuticals Of New York, LLC on Jan 15, 2024 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications: Out of specification for unknown impurity. The recall status is terminated (terminated Jan 31, 2025). Affected quantity: 858 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 14, 2024
- Initiation Date
- Jan 15, 2024
- Termination Date
- Jan 31, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 858 bottles
Product description
Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd, Oral Solid Dosage Unit, Ahmedabad 382213, India, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 60219-1502-01
Reason for recall
Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.
Distribution pattern
USA nationwide.
Code information
Lot # AM221153, Exp. date 06/30/2024; AM230497, Exp. date 02/29/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0319-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026